Search
for
Sort by
Research 61–90 of 164
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Lipid nanocarriers as innovative strategies for hair regrowth
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Consider Cultural Practices and Barriers to Care When Treating Alopecia Areata
- Th1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Alopecia areata
- ПОРІВНЯЛЬНИЙ АНАЛІЗ МЕТОДІВ ВІДНОВЛЕННЯ ВОЛОССЯ В УКРАЇНІ ТА США
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata